Chung Wu Investment Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.82K Hold
200
– – ﹤0.01% 254
2026
Q1
$5.62K Hold
200
– – ﹤0.01% 226
2025
Q4
$4.98K Hold
200
– – ﹤0.01% 238
2025
Q3
$5.1K Buy
+200
New +$4.94K ﹤0.01% 236

Other funds holding PFE

Chung Wu Investment Group's PFE Position: Q2 2026 in Review

Chung Wu Investment Group held its Pfizer (PFE) position steady in Q2 2026 at 200 shares worth $4.82K. The position accounts for ﹤0.01% of the portfolio, ranked #254.

Chung Wu Investment Group first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.62K in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Chung Wu Investment Group held 200 shares of Pfizer worth $4.82K as of Q2 2026.
  • Chung Wu Investment Group left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up ﹤0.01% of Chung Wu Investment Group's portfolio in Q2 2026, its #254 holding.
  • Chung Wu Investment Group first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • Chung Wu Investment Group's Pfizer position peaked at $5.62K in Q1 2026.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Chung Wu Investment Group's 13F filing for Q2 2026, filed 31 Jul 2026.